Product
PRS-220
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase 1, Randomized, Blinded, Placebo Controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PRS 220 Administered by Oral Inhalation in Healthy Subjects.Status: Completed, Estimated PCD: 2023-08-11